Early Phase 1 Atherosclerosis Clinical Trials
3 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome.
Atherosclerosis
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.18 enrolled2 locationsNCT06788431
Completed
Early Phase 1
The effect of statins on circulating concentrations of the hormone C-type natriuretic peptide
Atherosclerosis
Christchurch Heart Institute60 enrolled1 locationACTRN12613000525785
Recruiting
Early Phase 1
The Tetherx Natural Vascular Scaffolding (NVS) Procedure for Treating Patients with Atherosclerosis of the Femoropopliteal Artery
Symptoms of claudication or ischemic rest pain (Rutherford category 2, 3, or 4) with suspected atherosclerosis in either the superficial femoral artery or the proximal popliteal artery (above the knee articulation).
Tetherx, Inc.30 enrolled1 locationACTRN12611000897965